financetom
Business
financetom
/
Business
/
Marsh & McLennan Q1 Adjusted Earnings, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Marsh & McLennan Q1 Adjusted Earnings, Revenue Increase
Apr 18, 2024 4:39 AM

07:27 AM EDT, 04/18/2024 (MT Newswires) -- Marsh & McLennan ( MMC ) reported Q1 adjusted earnings early Thursday of $2.89 per diluted share, up from $2.53 a year earlier.

Analysts polled by Capital IQ expected $2.80.

Revenue for the quarter ended March 31 was $6.47 billion, compared with $5.92 billion a year earlier.

Analysts surveyed by Capital IQ expected $6.40 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Excelerate Energy Prices Upsized $184.3 Million Share Offering
Excelerate Energy Prices Upsized $184.3 Million Share Offering
Apr 1, 2025
03:26 AM EDT, 04/01/2025 (MT Newswires) -- Excelerate Energy ( EE ) said late Monday it priced an upsized underwritten public offering of $184.3 million of class A shares at $26.50 apiece. The company is offering nearly 7 million class A shares in the offering, which was upsized from the initial $150 million. The firm has granted underwriters a 30-day...
Soleno Therapeutics Insider Sold Shares Worth $1,013,627, According to a Recent SEC Filing
Soleno Therapeutics Insider Sold Shares Worth $1,013,627, According to a Recent SEC Filing
Apr 1, 2025
03:25 AM EDT, 04/01/2025 (MT Newswires) -- Michael F. Huang, Senior Vice President of Clinical Development, on March 27, 2025, sold 14,583 shares in Soleno Therapeutics ( SLNO ) for $1,013,627. Following the Form 4 filing with the SEC, Huang has control over a total of 36,817 common shares of the company, with 36,817 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1484565/000141588925009294/xslF345X05/form4-03312025_110347.xml...
Soleno Therapeutics Insider Sold Shares Worth $10,709,353, According to a Recent SEC Filing
Soleno Therapeutics Insider Sold Shares Worth $10,709,353, According to a Recent SEC Filing
Apr 1, 2025
03:26 AM EDT, 04/01/2025 (MT Newswires) -- Patricia C Hirano, Senior Vice President, Regulatory Affairs, on March 27, 2025, sold 156,315 shares in Soleno Therapeutics ( SLNO ) for $10,709,353. Following the Form 4 filing with the SEC, Hirano has control over a total of 30,818 common shares of the company, with 30,818 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1484565/000141588925009291/xslF345X05/form4-03312025_110320.xml ...
BRIEF-Inventec Plans To Sign Joint Agreement With AMD To Sell Its Stake In ZT Group To AMD
BRIEF-Inventec Plans To Sign Joint Agreement With AMD To Sell Its Stake In ZT Group To AMD
Apr 1, 2025
April 1 (Reuters) - Inventec: * : PLANS TO SIGN JOINT AGREEMENT WITH AMD TO SELL ITS STAKE IN ZT GROUP INTERNATIONAL TO AMD FOR T$13.4 BILLION ($403.6 MLN) Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved